Top Markets
Coin of the day
Bio-Path Holdings, Inc. Bio-Path Holdings, Inc.

Bio-Path Holdings, Inc.

BPTH
Classement en actions #39844
Bio-Path Holdings, Inc. is a U.S.-based pharmaceutical company focused on... Bio-Path Holdings, Inc. is a U.S.-based pharmaceutical company focused on developing RNAi nanoparticle drugs for oncology, with programs spanning both clinical and preclinical stages. Its innovative product development is centered around the DNAbilize platform, a drug delivery and antisense technology that employs a P-ethoxy modified deoxyribonucleic acid (DNA) backbone. This modification is specifically engineered to shield the DNA from premature degradation. The company's lead drug candidate, prexigebersen, is presently in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. Additionally, Bio-Path is advancing Liposomal Bcl-2 for refractory/relapsed lymphoma and chronic lymphocytic leukemia. Another promising asset, Liposomal STAT3, is in preclinical development, targeting pancreatic cancer, non-small cell lung cancer, and AML. Furthermore, prexigebersen-A is under development for various solid tumors. Bio-Path Holdings, Inc., founded in 2007, is headquartered in Bellaire, Texas.
Prix de l'action
$0.035
Dernière synchronisation: 2026-08-13
Capitalisation boursière
$326.98K
Changement (1 jour)
-12.50%
Changement (1 an)
-74.55%
Pays
US
Échange Bio-Path Holdings, Inc. (BPTH)

Catégorie

Historique du prix de l'action pour Bio-Path Holdings, Inc. (BPTH)
Prix de clôture le plus élevé : $0.04 le 2026-08-01

Prix de clôture le plus bas : $2.50K le 2006-02-01
Historique du prix de l'action de Bio-Path Holdings, Inc. de 2006 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -9.36%
2025 -91.80%
2024 -91.13%
2023 -66.41%
2022 -65.24%
2021 16.03%
2020 -52.69%
2019 59.95%
2018 -88.85%
2017 -82.76%
2016 -18.86%
2015 -40.35%
2014 -11.72%
2013 803.53%
2012 3.58%
2011 -14.96%
2010 -14.88%
2009 4.80%
2008 -52.90%
2007 18.00%
2006 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.07K -6.27%
KR
$259.89 14.81%
BE